Medicine & Life Sciences
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
34%
Acute Kidney Injury
100%
Acute Tubulointerstitial Nephritis
17%
Allogeneic Cells
16%
BK Virus
20%
bosutinib
25%
Cell Transplantation
16%
Chronic Renal Insufficiency
34%
Cidofovir
21%
Creatinine
19%
Critical Illness
27%
Dasatinib
29%
Dialysis
31%
Emergencies
17%
Erythema elevatum diutinum
21%
Glomerular Filtration Rate
21%
Hematologic Neoplasms
19%
Hematopoietic Stem Cell Transplantation
15%
Herpes Simplex
17%
Hybrid Renal Replacement Therapy
26%
Hyponatremia
39%
Imatinib Mesylate
26%
Immunocompromised Host
15%
Incidence
25%
Interstitial Nephritis
19%
Kidney
67%
Kidney Diseases
62%
Kidney Neoplasms
33%
Length of Stay
14%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15%
Leukemia, Myeloid, Chronic Phase
29%
Mortality
24%
Multiple Myeloma
40%
Myelodysplastic Syndromes
16%
Neoplasms
48%
Nephrologists
17%
Nephrology
55%
Odds Ratio
18%
Oncologists
15%
Paraproteins
21%
Philadelphia Chromosome
19%
Renal Insufficiency
16%
Safety
19%
Schoenlein-Henoch Purpura
20%
Survival
16%
Therapeutics
19%
Tolvaptan
23%
trifluridine tipiracil
26%
Wounds and Injuries
15%